Comments
Pharmaceuticals major, Torrent Pharma Limited on Monday informed that the company has acquired two of the popular brands for women healthcare from the Swiss Pharma major Novartis AG for the Indian market.
Torrent acquired Regestrone and Pregachieve brands for India from global Pharma player Novartis AG, Switzerland.
The brands, widely prescribed by Gynaecologists for the management of Abnormal Uterine bleeding, Peri & Post- menopausal symptoms and Infertility will now be under the Torrent portfolio.
"Women Healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased," the company stated in a statement.
"Regestrone and Pregachieve will further fortify the Hormone Segment. The use of Hormones amongst the Gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare," it said.
Torrent Pharma shares ended at Rs 1281 on the National Stock Exchange (NSE) On Monday after loss of close to 1 per cent.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.